| Prev Close | 110.15 |
| Day Low/High | 109.51 / 110.33 |
| 52 Wk Low/High | 86.16 / 128.54 |
Abbott Laboratories (ABT)
109.91
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1776.82B |
| Market Cap | 195.72B |
| P/E Ratio | 60.02 |
| Div & Yield | N.A. (N.A) |
Latest News
Best Stocks With DRIP Plans Right Now
These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.
Key Chart Favors a Nice Rise in Abbott Labs Later This Year
The technical signals indicate the odds of further weakness in the health care company's shares are low.
Investors on United Airlines Could See a Bumpy Ride Ahead
Consider other 'travel plans.'
New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM
Always, always, always stick to your rules. Always. This is why we have targets, pivots and panics.
We've Changed Our Strategy on Abbott Laboratories
The charts are more mixed now.
Revisiting an S&P 500 Chart Setup and Tracking 2 Stocks on Pullbacks
Microsoft and Abbott Laboratories are the names that are worth watching.
Jim Cramer: There's Good Risk and Bad Risk
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
Here's a Quick Technical Update on Abbott Laboratories
Traders should continue to hold existing longs on ABT.
Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
Abbott Labs Has the Formula for a Long Trade
ABT has made an upside breakout on the daily Point and Figure chart, and here's how investors can make their next move.
Jim Cramer: You Just Won Powerball, Now What?
Remember, you only need to get rich once.
8 Quality Dividend Stocks for Durable Growth and Income
Four experts highlight their favorite dividend stocks for 2021.
Jim Cramer: Misconceptions About Covid-19 and Wagering on Its Longevity
Maybe we will be better when Covid 2021 comes around. But sustainable? Ha. How about inevitable?
Abbott Laboratories Could Soon Break Out From Its Sideways Pattern
Let's review the charts and indicators.
Jim Cramer: 8 Stocks That Benefit the Most If There's Another Modified Lockdown
These companies have spent the last six months preparing for a second lockdown betting it will occur.
Jim Cramer: Health Care Stocks, the Election and the Perfect Setup
Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.
Does Abbott Labs Still Pass My Test After Earnings?
Diagnostics revenue grew an impressive 38% due to the necessity of Covid-19 testing.
'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed
There is a presidential debate on Thursday. The market is being forced to adjust for renewed potential uncertainty.
Jim Cramer: This Is How Stocks Would Fare Under a President Biden
I don't pick stocks on politics, but was shocked to see how a majority of our Action Alerts PLUS holdings would perform if Joe Biden wins the White House.
Jim Cramer: Better to Mask and Test Than Wait for Vaccine
New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.
Jim Cramer: Fly Ahead of the Pack on Boeing
People want to wait and see on this beleaguered aviation name, but I don't think you can do that. Here's why.
Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.
Neither candidate seems to be the enemy of the market -- at least not yet.
Abbott Labs Stock Could Still Slip Lower
Let's review the charts and indicators.
Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
This Dividend Stock's Got the Right Medicine for Investors
AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.
Charting the Best Hotels in the Sector
We grade Choice Hotels, Hilton and Marriott, and check on the opportunities each offers.
